(NASDAQ: AHCO) Adapthealth's forecast annual revenue growth rate of 9.66% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Adapthealth's revenue in 2026 is $3,255,213,000.On average, 10 Wall Street analysts forecast AHCO's revenue for 2026 to be $475,339,412,340, with the lowest AHCO revenue forecast at $451,504,729,556, and the highest AHCO revenue forecast at $491,184,059,418. On average, 7 Wall Street analysts forecast AHCO's revenue for 2027 to be $518,268,926,218, with the lowest AHCO revenue forecast at $484,412,842,718, and the highest AHCO revenue forecast at $563,500,653,774.
In 2028, AHCO is forecast to generate $591,262,642,244 in revenue, with the lowest revenue forecast at $567,969,656,796 and the highest revenue forecast at $608,596,956,996.